The role of perfusion computed tomography in the prediction of cerebral hyperperfusion syndrome
- PMID: 21625479
- PMCID: PMC3098834
- DOI: 10.1371/journal.pone.0019886
The role of perfusion computed tomography in the prediction of cerebral hyperperfusion syndrome
Abstract
Background: Hyperperfusion syndrome (HPS) following carotid angioplasty with stenting (CAS) is associated with significant morbidity and mortality. At present, there are no reliable parameters to predict HPS. The aim of this study was to clarify whether perfusion computed tomography (CT) is a feasible and reliable tool in predicting HPS after CAS.
Methodology/principal findings: We performed a retrospective case-control study of 54 patients (11 HPS patients and 43 non-HPS) with unilateral severe stenosis of the carotid artery who underwent CAS. We compared the prevalence of vascular risk factors and perfusion CT parameters including regional cerebral blood volume (rCBV), regional cerebral blood flow (rCBF), and time to peak (TTP) within seven days prior to CAS. Demographic information, risk factors for atherosclerosis, and perfusion CT parameters were evaluated by multivariable logistic regression analysis. The rCBV index was calculated as [(ipsilateral rCBV - contralateral rCBV)/contralateral rCBV], and indices of rCBF and TTP were similarly calculated. We found that eleven patients had HPS, including five with intracranial hemorrhages (ICHs) of whom three died. After a comparison with non-HPS control subjects, independent predictors of HPS included the severity of ipsilateral carotid artery stenosis, 3-hour mean systolic blood pressure (3 h SBP) after CAS, pre-stenting rCBV index >0.15 and TTP index >0.22.
Conclusions/significance: The combination of severe ipsilateral carotid stenosis, 3 h SBP after CAS, rCBV index and TTP index provides a potential screening tool for predicting HPS in patients with unilateral carotid stenosis receiving CAS. In addition, adequate management of post-stenting blood pressure is the most important treatable factor in preventing HPS in these high risk patients.
Conflict of interest statement
Figures


References
-
- Golledge J, Mitchell A, Greenhalgh RM, Davies AH. Systematic comparison of the early outcome of angioplasty and endarterectomy for symptomatic carotid artery disease. Stroke. 2000;31:1439–1443. - PubMed
-
- Hobson RW, 2nd, Brott T, Ferguson R, Roubin G, Moore W, et al. Crest: Carotid revascularization endarterectomy versus stent trial. Cardiovasc Surg. 1997;5:457–458. - PubMed
-
- Malek AM, Higashida RT, Phatouros CC, Lempert TE, Meyers PM, et al. Stent angioplasty for cervical carotid artery stenosis in high-risk symptomatic nascet-ineligible patients. Stroke. 2000;31:3029–3033. - PubMed
-
- McCabe DJ, Brown MM, Clifton A. Fatal cerebral reperfusion hemorrhage after carotid stenting. Stroke. 1999;30:2483–2486. - PubMed
-
- Meyers PM, Higashida RT, Phatouros CC, Malek AM, Lempert TE, et al. Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries. Neurosurgery. 2000;47:335–343; discussion: 343-335. - PubMed